BFRI
BFRI clinical trials: Biofrontera Inc.
Every trial on ClinicalTrials.gov where Biofrontera Inc. is the lead sponsor or a listed collaborator, the trials it leads first, each labelled Lead or Collaborator. Phase, status and dates as registered.
- 15
- Trials linked
- 10
- As lead sponsor
- 5
- As collaborator
- 0
- Primary completions as lead sponsor, next 90 days
BFRI on the catalyst calendar · BFRI registry changes
- Primary completion Aug 22, 2025ActualPhase 2NCT05080764Study to Evaluate the Safety and Efficacy of BF-200 ALA (Ameluz®) and BF-RhodoLED® in the Treatment of Moderate to Severe Acne Vulgaris...Biofrontera Inc. · Acne VulgarisCompletedBFRILead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Sep 3, 2025ActualPhase 3NCT05662202Study to Evaluate the Safety, Tolerability and Efficacy of BF-200 ALA (Ameluz®) in the Field-directed Treatment of Actinic Keratosis...Biofrontera Inc. · Actinic KeratosesCompletedBFRILead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Mar 19, 2024ActualPhase 3NCT03573401Study to Evaluate the Safety and Efficacy of BF-200 ALA (Ameluz®) and BF-RhodoLED® in the Treatment of Superficial Basal Cell Carcinoma...Biofrontera Inc. · Superficial Basal Cell CarcinomaActive, not recruitingBFRILead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Apr 20, 2023ActualPhase 1NCT05060237Study to Evaluate Safety and Tolerability of BF-200 ALA (Ameluz®) for Photodynamic Therapy in the Treatment of the Expanded Field of...Biofrontera Bioscience GmbH · Actinic KeratosisCompletedBFRILead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Sep 2014ActualPhase 3NCT01966120Safety and Efficacy Study for the Field-directed Treatment of Actinic Keratosis (AK) With Photodynamic Therapy (PDT)Biofrontera Bioscience GmbH · Actinic KeratosisCompletedBFRILead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Nov 17, 2015ActualPhase 3NCT02144077Safety and Efficacy Study for the Treatment of Non-Aggressive Basal Cell Carcinoma With Photodynamic TherapyBiofrontera Bioscience GmbH · Basal Cell Carcinoma (BCC)CompletedBFRILead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Sep 9, 2020ActualPhase 1NCT04319159Study to Evaluate the Safety of BF-200 ALA (Ameluz®) for Photodynamic Therapy (PDT) in the Treatment of Expanded Fields of Actinic...Biofrontera Bioscience GmbH · Actinic KeratosesCompletedBFRILead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Oct 2008ActualPhase 3NCT02799082Evaluation of Efficacy and Safety of BF-200 ALA Used With Photodynamic Therapy in Patients With Actinic Keratosis.Biofrontera Bioscience GmbH · Actinic KeratosisCompletedBFRILead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Aug 2009ActualPhase 3NCT02799069Evaluation of Safety and Efficacy of BF-200 ALA for the Treatment of Actinic Keratosis With Photodynamic TherapyBiofrontera Bioscience GmbH · Actinic KeratosisCompletedBFRILead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Mar 2007ActualPhase 2NCT02799030A Clinical Trial of Topical Photodynamic Therapy With 5-aminolevulinic Acid for the Treatment of Actinic KeratosisBiofrontera Bioscience GmbH · Actinic KeratosisCompletedBFRILead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Oct 13, 2026Sponsor estimatePhase 4NCT06745999Cryotherapy in Combination With Red Light PDT for Actinic Keratosis of Full FacePsoriasis Treatment Center of Central New Jersey · Actinic KeratosesActive, not recruitingBFRICollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 29, 2025ActualPhase 1NCT07053852Activation of Ameluz With BBL HEROic for the Treatment of Actinic Keratoses and PhotodamageSherrif Ibrahim · Actinic KeratosesCompletedBFRICollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jul 8, 2024ActualPhase 2NCT06027619Short Contact Protocols to Reduce Pain During 10% ALA Gel Red-light Photodynamic Therapy of Actinic KeratosesCase Comprehensive Cancer Center · Actinic KeratosisCompletedBFRICollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Aug 2025Sponsor estimatePhase 2NCT06577311Evaluating the Use of Photodynamic Therapy to Treat Facial Cutaneous Squamous Cell Carcinoma in Situ (SCCis)The Center for Clinical and Cosmetic Research · Cutaneous Squamous Cell CarcinomaUnknown statusBFRICollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Aug 30, 2023Sponsor estimatePhase 4NCT05359419Comparison of Two Modes of Photodynamic Therapy for the Treatment of Actinic Keratosis on the Upper ExtremitiesGoldman, Butterwick, Fitzpatrick and Groff · Skin NeoplasmsUnknown statusBFRICollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
Enrollment, interventions and the start and completion dates are locked on 15 rows here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.
Unlock with TrialScanner